Back to Search Start Over

Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy.

Authors :
Stern WM
Winston JS
Murphy E
Cross JH
Sander JW
Source :
Practical neurology [Pract Neurol] 2017 Jun; Vol. 17 (3), pp. 207-211. Date of Electronic Publication: 2017 Jan 24.
Publication Year :
2017

Abstract

Epilepsy commonly presents in childhood as part of a syndrome, and some such children may reach adult services without an underlying syndromic diagnosis. For adult neurologists taking over their care, it is often unclear how hard to search for an underlying diagnosis. The diagnostic yield may be small and such a diagnosis may not change management. Young adults with learning difficulties are also challenging to investigate, as they may not tolerate standard epilepsy tests.We present such a case in which simple tests identified a unifying diagnosis. With the new diagnosis came a new treatment that had a significant impact on seizures and quality of life.<br />Competing Interests: Competing interests: JWS has received speaker honoraria from GlaxoSmithKline, Eisai, UCB, Lundbeck and Teva and was a member of the advisory boards for UCB and Eisai. He receives research support from the Dr Marvin Weil Epilepsy Research Fund, the Epilepsy Society (UK), the Netherlands Epilepsy Fund, Eisai, GlaxoSmithKline and UCB. He serves on the editorial board of the Lancet Neurology and his current position is endowed by the Epilepsy Society (UK). EM has received unrestricted educational grant funding and travel support from Genzyme and Shire Pharmaceuticals and funding for clinical trial work from Vitaflo, Ultragenyx, Genzyme, Shire and BiomarinPharmaceuticals. JSW is supported by a Wellcome Trust Postdoctoral Training Fellowship for MB/PhD Graduates (095939) and the Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust (091593). JHC has received (all paid to her department) research monies from Vitaflo and GW Pharma, honoraria for advisory boards from Nutricia, Shire, Takeda, Eisai and GSK, and honoraria for speaking by Nutricia, Eisai, UCB and Shire, outside the submitted work.<br /> (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)

Details

Language :
English
ISSN :
1474-7766
Volume :
17
Issue :
3
Database :
MEDLINE
Journal :
Practical neurology
Publication Type :
Academic Journal
Accession number :
28119378
Full Text :
https://doi.org/10.1136/practneurol-2016-001475